PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto, Porto, Portugal.\', \'LAQV@REQUIMTE, University of Porto, Porto, Portugal.\', \'Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal.\', \'Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.\', \'Department of Immuno-Physiology and Pharmacology, ICBAS-UP, Porto, Portugal.\', \'Department of Gastroenterology, Centro Hospitalar São João, Porto, Portugal.\', \'MedInUP, Center for Drug Discovery and Innovative Medicines, Porto, Portugal.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ibd/izaa249
?:doi
?:hasPublicationType
?:journal
  • Inflammatory bowel diseases
is ?:pmid of
?:pmid
?:pmid
  • 33064147
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.511
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33064147>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33064147>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all